GeneralConnection.com ➔ Dictionary
Dictionary Search

enbrel

Synonyms

Noun

1. etanercept

2. Enbrel, anti-TNF compound

Usage
Median price of Enbrel in selected countries in 2022 (in U.S. dollars) - Statista
After Colorado put a price cap on its drug, Amgen sued the state board that did it. Again. - The Colorado Sun
Colorado becomes first state to cap prescription drug prices, starting with Enbrel - Denver7
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times
States fed up with high drug prices are cracking down - The Washington Post
Amgen sues Colorado over state’s first-in-the-nation price ceiling on arthritis drug Enbrel - The Denver Post
Litigation over State Attempts to Lower Drug Costs: Prescription Drug Affordability Boards (PDABs) - Every CRS Report
Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar - Law360
Medicare coverage for Enbrel: Costs, eligibility, and more - Medical News Today
Colorado becomes first state to cap price of prescription drug - Colorado Newsline
Enbrel Kidney Side Effects Continue To Be Reported After FDA Glomerulonephritis Warning - AboutLawsuits.com
Colorado board makes first-in-the-nation move by setting a payment limit on an Amgen drug - statnews.com
Amgen gets quick appeal in CareFirst’s US antitrust case over Enbrel - MLex
AAM Comments on Colorado PDAB Pricing Announcement - Association for Accessible Medicines
Did Pfizer Really Hide Info About a Drug That "Could Prevent Alzheimer’s?" Not So Fast, Say Researchers - Being Patient
Safety and Efficacy of Perispinal Etanercept for Chronic Stroke - Neurology® Journals
Colorado just became the first state to cap the price of a prescription drug. What comes next is uncertain. - The Colorado Sun
Amgen revenue from Enbrel by region 2011-2025 - Statista
Colorado sets first-in-the-nation price ceiling on a prescription drug - The Denver Post
Sandoz's Case Against Amgen Over Enbrel Biosimilar Tossed - Law360
Amgen gets quick appeal in CareFirst's US case over Enbrel - MLex
Drugmaker sues Colorado over first of its kind law setting price ceiling on drug - KUSA.com
Colorado prescription board votes to limit cost of rheumatoid arthritis drug - Colorado Politics
Colorado needs to take action on skyrocketing drug prices | OPINION - Colorado Politics
Biocon Biologics launches Nepexto, a Biosimilar to Enbrel (Etanercept), in Australia - BioSpectrum Asia
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis - Amgen
Amgen files reply in support of quick appeal in CareFirst’s US case over Enbrel - MLex
Drug Savings Doubted for Colorado as State Nears First Pay Cap - Bloomberg Law News
Stelara and Enbrel Chosen for IRA Price Negotiation - Center for Biosimilars
Comparing Rheumatoid Arthritis Treatments: Enbrel vs. Humira - Healthline
A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug - BioPharma Dive
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit - Pharmaceutical Technology
Arrotex & Pfizer Partner on Etanercept in Australia - Pearce IP
Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients - Amgen
Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany - Lupin | Press Release - lupin.com
FDA APPROVES ENBREL AS FIRST THERAPY TO INHIBIT BONE AND JOINT DAMAGE IN PSORIATIC ARTHRITIS PATIENTS - Amgen
In a New Clinical Study, Enbrel Taken Once Weekly Significantly Reduced Pain and Inflammation and Improved Function in Rheumatoid Arthritis Patients - Amgen
Enbrel Biosimilar Works Well, Yet Some Patients Still Prefer the Originator Drug - CreakyJoints
Stable Treatment Persistence in RA After Etanercept Biosimilar Introduction in Australia - Center for Biosimilars
List Prices of Enbrel, Stelara Slashed by Close to 70% Through Medicare Price Negotiations - The Dermatology Digest
Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel - Fierce Pharma
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season - TradingView
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year - Fierce Pharma
Lupin submits New Drug Application for Etanercept biosimilar in Japan - Lupin | Press Release - lupin.com
Enbrel cost 2026: Coupons and more - Medical News Today
Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke - NeurologyLive
Amgen Wins Patent Case On Enbrel® (etanercept) - Amgen
Amgen Receives Victory in Arthritis Drug Enbrel Case - Docwire News
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia - PharmaDispatch
Pharmaceutical company Amgen sues Colorado over price-setting prescription drug board - The Colorado Sun
Stopping Enbrel Risky in Established RA - MedPage Today
Etanercept biosimilars delayed until 2029 in US - Generics and Biosimilars Initiative
What Happens When an Anti-TNF Fails for RA - Arthritis Foundation
Amgen Wins Appeals Court Ruling Upholding Patents on Enbrel (3) - Bloomberg Law News
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world? - The Washington Post
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions - PR Newswire
Novartis challenge to Amgen’s Enbrel patents ends at Supreme Court’s door - BioPharma Dive
Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board - The Colorado Sun
Enbrel Stays Above the Biosimilar Fray, but Humira Biosimilars May Nip at its Heels - Managed Healthcare Executive
First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate - PR Newswire
Pfizer Reports Continued Weakness for Enbrel in Europe - Center for Biosimilars
US supreme court ends Sandoz–Amgen biosimilar dispute - Chemistry World
Amgen wins latest round in legal tussle over Enbrel patents - pharmaphorum
Sandoz Attacks Amgen Over US Enbrel Exclusivity - Citeline News & Insights
Is It Safe to Taper Biologics in Rheumatoid Arthritis Once You Achieve Low Disease Activity? Here’s What a New Study Says About It - CreakyJoints
FDA approves Eticovo, second Enbrel biosimilar - Healio
Biogen Announces Benepali™ (Etanercept) is the First Biosimilar of Enbrel® to Receive a Positive Opinion from CHMP - Biogen
BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in the European Union - Biogen
Agency Press Release Page - CT.GOV-Connecticut's Official State Website (.gov)
U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel - Reuters
The Little-Known Way Pharma Companies Hook People On Their Costly Drugs - Time Magazine
Stelara and Enbrel Chosen for IRA Price Negotiation - AJMC
Etanercept as Monotherapy in Patients with Psoriasis - The New England Journal of Medicine
Pfizer takes to Twitter to refute ‘Washington Post’ story - Medical Marketing and Media
The structure-function relationship of disulfide bonds in etanercept - Nature
Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions (Published 2016) - The New York Times
New Study Finds That Taking TNF Inhibitor Biologics Does Not Raise Cancer Risk in Cancer Survivors - CreakyJoints
Enbrel patent surfaces - Nature
Amgen Does Not Expect Big Enbrel Price Impact From US Humira Biosimilar Launches - Citeline News & Insights
Biosimilar Etanercept Similar to Enbrel in Persistence of Treatment, Cost Savings for Patients With RA - Center for Biosimilars
Biosimilars of etanercept - Generics and Biosimilars Initiative
Amgen Hit By Enbrel 'Peculiarities' And Repatha Resistance - Citeline News & Insights
Colorado prescription drug board declares Enbrel unaffordable in national first - The Denver Post
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis - Reuters
What do kids think of their parents' RA? Amgen's new Enbrel push offers a few ideas - Fierce Pharma
Pfizer Did Not Pursue Possible Evidence of Enbrel Helping with Alzheimer's Due to Low Chance of Clinical Success - BioSpace
Opinion | It’s silly to think Pfizer would pass on an Alzheimer’s drug trial without good reasons - The Washington Post
The Colorado state prescription drug board declares Enbrel unaffordable in national 1st - The Guam Daily Post
Amgen Avoids Supreme Court Review of Patents on Enbrel Drug - Bloomberg.com
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong - Arnold Ventures
Enbrel Lawsuits - AboutLawsuits.com
Federal judge dismisses lawsuit challenging Colorado's power to cap prescription drug costs - Denver7
Enbrel and the Autoimmune Era - The Atlantic
Success for Bioepis as FDA approves a second Enbrel biosimilar - BioProcess International
Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis - PR Newswire
Biologic Therapy for Rheumatoid Arthritis and Risk of Skin Cancer - news.cancerconnect.com
Humira, Enbrel, Similar Drugs May Increase Risks of Inflammatory Central Nervous System Events: Study - AboutLawsuits.com
The first Humira biosim is doing Amgen more harm than good—for now - Fierce Pharma
Sarcoidosis Can Be Both Triggered and Treated by Same Type of Therapy - Sarcoidosis News
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug - Reuters
Foreign Language Equivalents
Foreign Language Equivalents of 'enbrel'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
enbrek,   enbbrel,   nbrel,   enbre,   enbreel,   ebrel,   enbtel,   enrbel,   wnbrel,   enbrl,   enbrrel,   enbrell,   nebrel,   ebnrel,   enbel,   ennbrel,   eenbrel,   embrel,   enberl,   enrel,   enbrrl,   enbeel,   ebbrel,   rnbrel,   envrel,   enbrle,   enbrwl,   ennrel,   enbre;
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z